… Based on our review of the available models, while there are promising advances in
modelling capability, particularly in relation to rate of absorption, none are yet capable of …

… Based on the results of the review, revised restricted medication rules for the use of NSAIDs
and other medications were agreed on with an external steering committee for the TULIP …

… of monoclonal antibodies. They are attracting great attention in diverse clinical translations
on account of their … This Review aims to provide a deeper understanding of the research and …

… Billions of dollars are invested into the monoclonal antibody … in bio-related applications,
this review also pointed out the … antibodies, so as to jointly lead the future development trend. …

… In this review, we briefly outline the beneficial properties of camelid nanobodies in … than
classical monoclonal antibodies, which is obviously crucial for therapeutic applications [39, 61]. …

… In this review, we outline these advances, focusing on BsAb drugs, their targets, and their …
Since no immunomodulatory BsAbs are currently in clinical trials for MM, this review will …

… conjugates, these entities were met with limited clinical success. This review summarizes
the … consideration for both monoclonal antibody therapeutics and ADC therapeutics [23]. Fc-…

… This review provides a comprehensive examination of the … their design, mechanisms of action,
and clinical applications. The … landscape of monoclonal antibody-mediated therapy. These …

… Here, we review the progress and the therapeutic potential for this class of antibodies, as …
agent consisting of a murine IgM monoclonal antibody labeled with technetium-99m ( 99m Tc). …

… The NIH institutional review board reviewed and approved the trial protocol. All participants
… a pharmacokinetic profile aligned with potential clinical use across a variety of settings. …